Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients Vasomune Therapeutics, Inc., a clinical-stage biopharmaceutical company, today announced U.S. Food and Drug Administration…
MED-EL U.S. Launches Two New Rechargeable Battery Options with up to 23 Hours of Hearing for the SONNET 3 Audio Processor MED-EL U.S. announced today two new rechargeable battery options: the Standard Pro and the Micro Pro. The new options…
Lucidis® Sets High Standards in Premium Cataract Surgery with Full-Range Vision Performance Swiss Advanced Vision announces new clinical evidence confirming the exceptional performance of its Lucidis® intraocular lens (IOL), strengthening its position as a disruptive solution in premium cataract surgery.…
Zoetis moves to acquire the animal genomics unit of Neogen, strengthening its precision animal health capabilities. Zoetis Inc. the world’s leading animal health company, today announced it has entered into a definitive agreement with Neogen Corporation (NASDAQ: NEOG) (“Neogen”) to…
Novocure’s Leadership to Highlight Innovative Cancer Therapy at Prestigious Event Why should healthcare investors and oncology professionals be paying attention to Novocure’s upcoming participation in the Leerink Global Healthcare Conference? Novocure, a global oncology company headquartered in Baar, Switzerland, is…
New Data Supports Next-Phase Development of Targeted Alpha Therapy Why is the treatment landscape for metastatic castration-resistant prostate cancer (mCRPC) so challenging? Despite significant advances, the prognosis for men with mCRPC remains poor, with a median survival of about 31…
New Combination Therapy Demonstrates 47% Reduction in Event-Free Survival Events Why is this a game-changer for bladder cancer treatment? Merck, a global leader in healthcare, has announced groundbreaking results from the Phase 3 KEYNOTE-B15 trial, which demonstrated that the combination…
Three-Year Data Confirm Revi’s Unmatched Durability and Patient Satisfaction Why is the treatment of urgency urinary incontinence (UUI) still a significant challenge for healthcare providers? BlueWind Medical, a leader in Implantable Tibial Neuromodulation (ITNM), has introduced the Revi® System, a…
Zai Lab’s 2025 Revenue Grows 17% YoY, Paving the Way for 2026 Oncology and Immunology Milestones What does the future hold for global oncology and immunology advancements? Zai Lab Limited a biopharmaceutical company based in China and the United States,…
Patent Expands Niagen’s Leadership in NAD+ Delivery, Supporting Faster and Safer Treatments Why is the race for intellectual property in the NAD+ market heating up? Niagen Bioscience, Inc. a global leader in NAD+ science and healthy aging, has announced the…
Real-World Impact of ZUNVEYL in Long-Term Care to Be Assessed What does the future hold for Alzheimer’s disease treatment in long-term care settings? Alpha Cognition Inc. a biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases, has announced the…
Ironwood Strengthens LINZESS Market Leadership and Prepares for Apraglutide Phase 3 Trials Why are biotechnology companies like Ironwood Pharmaceuticals crucial in addressing unmet needs in gastrointestinal diseases? Ironwood Pharmaceuticals, a biotechnology company headquartered in Boston, Massachusetts, is dedicated to developing…